X-group (possible homology)

3843 NADH-quinone oxidoreductase subunit K

Ligands and drugs

1,449
Member domains
156
with ligand contacts (≤ 4 Å)
10.8% of members
102
with DrugDomain annotations
7.0% of members
47
with a DrugBank compound
3.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

12
Proteins with classified ligands
3
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds15.80.17×q = 0.01
Hydrocarbons20.124×not tested
Lipids and lipid-like molecules91.36.83×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03429CDLTetrastearoyl cardiolipin47

Most frequently bound compounds

PDB ligandNameDomains in contact
3PE1,2-Distearoyl-sn-glycerophosphoethanolamine74
CDLCARDIOLIPIN60
T7XPhosphatidylinositol5
DU02-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol3
AJPDigitonin2
KmetalPOTASSIUM ION2
LFAEICOSANE2
PGT(1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE2
Q7G2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside2
3PH1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE1
BCRBETA-CAROTENE1
FMEN-FORMYLMETHIONINE1
LMG1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE1
PC11,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE1
PEE1,2-dioleoyl-sn-glycero-3-phosphoethanolamine1
SQD1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL1